hydrochlorothiazide has been researched along with Cardiomyopathies in 11 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with hypertensive heart disease, angiotensin-converting enzyme inhibition with lisinopril can regress myocardial fibrosis, irrespective of LVH regression, and it is accompanied by improved LV diastolic function." | 9.09 | Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. ( Brilla, CG; Funck, RC; Rupp, H, 2000) |
| "In patients with hypertensive heart disease, angiotensin-converting enzyme inhibition with lisinopril can regress myocardial fibrosis, irrespective of LVH regression, and it is accompanied by improved LV diastolic function." | 5.09 | Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. ( Brilla, CG; Funck, RC; Rupp, H, 2000) |
| " The study was designed as a side arm of INSIGHT (International Nifedipine Study: Intervention as Goal for Hypertension Therapy), aimed to show the efficacy of nifedipine once daily versus co-amilozide (hydrochlorothiazide 25 mg, amiloride 2." | 5.09 | Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. ( Motro, M; Shemesh, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Mattman, A | 1 |
| Masoudi, R | 1 |
| Stockler-Ipsiroglu, S | 1 |
| Zivkovic, I | 1 |
| Lehman, A | 1 |
| Dionne, JM | 1 |
| Hohl, M | 1 |
| Lauder, L | 1 |
| Sevimli, Ö | 1 |
| Tokcan, M | 1 |
| Wagmann, L | 1 |
| Götzinger, F | 1 |
| Schneider, C | 1 |
| Hübner, U | 1 |
| Lehnert, U | 1 |
| Meyer, MR | 1 |
| Böhm, M | 1 |
| Mahfoud, F | 1 |
| MILES, LE | 1 |
| Widman, L | 1 |
| Dyckner, T | 1 |
| Wester, PO | 1 |
| Hanton, G | 1 |
| Barnes, P | 1 |
| Shepperson, NB | 1 |
| Walley, R | 1 |
| Brilla, CG | 1 |
| Funck, RC | 1 |
| Rupp, H | 1 |
| Crespo, MJ | 1 |
| De Mello, WC | 1 |
| Motro, M | 1 |
| Shemesh, J | 1 |
| Mouallem, M | 1 |
| Friedman, E | 1 |
| Shemesh, Y | 1 |
| Mayan, H | 1 |
| Pauzner, R | 1 |
| Farfel, Z | 1 |
| Parry, EH | 1 |
| Yasui, H | 1 |
3 trials available for hydrochlorothiazide and Cardiomyopathies
| Article | Year |
|---|---|
Effect of moduretic and aldactone on electrolytes in skeletal muscle in patients on long-term diuretic therapy.
Topics: Cardiomyopathies; Humans; Hydrochlorothiazide; Hypertension; Magnesium; Muscles; Potassium; Spironol | 1982 |
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihyperte | 2000 |
Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics.
Topics: Aged; Amiloride; Calcinosis; Calcium Channel Blockers; Cardiomyopathies; Coronary Artery Disease; Di | 2001 |
8 other studies available for hydrochlorothiazide and Cardiomyopathies
| Article | Year |
|---|---|
Carnitine deficiency, hearing loss and hydrochlorothiazide-induced diabetes mellitus associated with the recurrent p.Trp85Arg variant in HNF4A.
Topics: Cardiomyopathies; Carnitine; Diabetes Mellitus, Type 2; Hearing Loss; Hepatocyte Nuclear Factor 4; H | 2022 |
Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats.
Topics: Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cardiomyopath | 2023 |
PUERPERAL CARDIOMYOPATHY ASSOCIATED WITH CLEIDOCRANIAL DYSOSTOSIS.
Topics: Anticoagulants; Cardiomyopathies; Cleidocranial Dysplasia; Diuretics; Electrocardiography; Female; H | 1964 |
Effects of hydrochlorothiazide and captopril on the survival and heart weight of cardiomyopathic hamsters.
Topics: Animals; Captopril; Cardiomyopathies; Cricetinae; Drug Therapy, Combination; Hydrochlorothiazide; Ma | 1993 |
Chronic administration of losartan plus hydrochlorothiazide improves vascular status in young cardiomyopathic hamsters.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta, Thoracic; Body Weight; Cardiomyopathies; Cri | 2001 |
Cardiac conduction defects associated with hyponatremia.
Topics: Adult; Aged; Amiloride; Cardiomyopathies; Female; Heart Block; Humans; Hydrochlorothiazide; Hyponatr | 1991 |
Ethiopian cardiovascular studies. II. Treatment of pulmonary oedema in outpatients.
Topics: Cardiomyopathies; Digoxin; Ethiopia; Heart Diseases; Heart Valve Diseases; Humans; Hydrochlorothiazi | 1968 |
The role of catecholamines in circulatory regulation on the chronic congestive heart failure. Clinical study of the urinary catecholamine excretion in the patients with chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiomyopathies; Catecholamines; Coronary Disease; Digital | 1968 |